Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.
Authors
Meyer, StefanFergusson, William D
Whetton, Anthony D
Moreira-Leite, Flavia
Pepper, Stuart D
Miller, Crispin J
Saunders, Emma K
White, Daniel J
Will, Andrew M
Eden, Tim O B
Ikeda, Hideyuki
Ullmann, Reinhard
Tuerkmen, Seval
Gerlach, Antje
Klopocki, Eva
Tönnies, Holger
Affiliation
Academic Unit of Paediatric Oncology, Christie Hospital Trust, University of anchester, Manchester, UK. stefan.meyer@manchester.ac.ukIssue Date
2007-04
Metadata
Show full item recordAbstract
Fanconi anemia (FA) is an inherited disease with congenital abnormalities and an extreme risk of acute myeloid leukemia (AML). Genetic events occurring during malignant transformation in FA and the biology of FA-associated AML are poorly understood, but are often preceded by the development of chromosomal aberrations involving 3q26-29 in bone marrow of FA patients. We report here the molecular cytogenetic characterization of FA-derived AML cell lines SB1685CB and SB1690CB by conventional and array comparative genomic hybridization, fluorescence in situ hybridization, and SKY. We identified gains of a 3.7 MB chromosomal region on 3q26.2-26.31, which preceded transformation to overt leukemia. This region harbors the oncogenic transcription factor EVI1. A third FA-derived cell line, FA-AML1, carried a translocation with ectopic localization of 3q26 including EVI1. Rearrangements of 3q, which are rare in childhood AML, commonly result in overexpression of EVI1, which determines specific gene expression patterns and confers poor prognosis. We detected overexpression of EVI1 in all three FA-derived AML. Our results suggest a link between the FA defect, chromosomal aberrations involving 3q and overexpression of EVI1. We hypothesize that constitutional or acquired FA defects might be a common factor for the development of 3q abnormalities in AML. In addition, cryptic imbalances as detected here might account for overexpression of EVI1 in AML without overt 3q26 rearrangements.Citation
Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. 2007, 46 (4):359-72 Genes Chromosomes CancerJournal
Genes, Chromosomes & CancerDOI
10.1002/gcc.20417PubMed ID
17243162Type
ArticleLanguage
enISSN
1045-2257ae974a485f413a2113503eed53cd6c53
10.1002/gcc.20417
Scopus Count
Related articles
- A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
- Authors: Storlazzi CT, Anelli L, Albano F, Zagaria A, Ventura M, Rocchi M, Panagopoulos I, Pannunzio A, Ottaviani E, Liso V, Specchia G
- Issue date: 2004 Feb
- Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
- Authors: Haferlach C, Bacher U, Grossmann V, Schindela S, Zenger M, Kohlmann A, Kern W, Haferlach T, Schnittger S
- Issue date: 2012 Dec
- EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
- Authors: Balgobind BV, Lugthart S, Hollink IH, Arentsen-Peters ST, van Wering ER, de Graaf SS, Reinhardt D, Creutzig U, Kaspers GJ, de Bont ES, Stary J, Trka J, Zimmermann M, Beverloo HB, Pieters R, Delwel R, Zwaan CM, van den Heuvel-Eibrink MM
- Issue date: 2010 May
- An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.
- Authors: Bobadilla D, Enriquez EL, Alvarez G, Gaytan P, Smith D, Slovak ML
- Issue date: 2007 Mar
- Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
- Authors: Nanjundan M, Nakayama Y, Cheng KW, Lahad J, Liu J, Lu K, Kuo WL, Smith-McCune K, Fishman D, Gray JW, Mills GB
- Issue date: 2007 Apr 1